Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on International Tech Times.
Press releases published on April 15, 2025
EngageLab Powers the Success of a Leading Chinese Cross-Border B2B E-Commerce Platform Amid U.S. Market Surge
GlobeNewswire
·
April 15, 2025
SINGAPORE, April 15, 2025 (GLOBE NEWSWIRE) -- EngageLab, a world-leading provider of AI-powered omnichannel customer engagement solutions, is proud to support the remarkable growth of a prominent Chinese cross-border B2B e-commerce platform, which recently …
Aurora Mobile’s EngageLab Powers the Success of a Leading Chinese Cross-Border B2B E-Commerce Platform Amid U.S. Market Surge
GlobeNewswire
·
April 15, 2025
SHENZHEN, China, April 15, 2025 (GLOBE NEWSWIRE) -- Aurora Mobile Limited (NASDAQ: JG) ("Aurora Mobile" or the "Company"), a leading provider of customer engagement and marketing technology services in China, today announced that its subsidiary EngageLab, …
Vallourec Invitation: Q1 2025 Results Release and Conference Call - Thursday, May 15th, 2025
GlobeNewswire
·
April 15, 2025
Q1 2025 Results Release and Conference Call Thursday, May 15th, 2025 Vallourec will publish First Quarter 2025 Results on May 15th, 2025 at 07:30 AM CET. Philippe Guillemot, Chairman of the Board and Chief Executive Officer, and Sascha Bibert, Chief …
[Latest] Global Transformer Core Market Size/Share Worth USD 12.7 Billion by 2034 at a 3.1% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
GlobeNewswire
·
April 15, 2025
Austin, TX, USA, April 15, 2025 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Transformer Core Market Size, Trends, and Insights” that covers various aspects like product types (Distribution Transformer, Power …
Oculis Hosts R&D Event Today to Showcase Progress on All Three Pipeline Assets
GlobeNewswire
·
April 15, 2025
ZUG, Switzerland, April 15, 2025 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS / XICE: OCS) (“Oculis” or the “Company"), a global biopharmaceutical company focused on innovations addressing ophthalmic and neuro-ophthalmic diseases with significant …
Concept Life Sciences expands expertise with key appointments to Scientific Advisory Board and investments to strengthen integrated drug discovery capabilities
GlobeNewswire
·
April 15, 2025
CHAPEL-EN-LE-FRITH, United Kingdom, April 15, 2025 (GLOBE NEWSWIRE) -- Concept Life Sciences (CLS), a leading integrated drug discovery, development, and manufacturing organisation backed by Limerston Capital, today announced key strategic appointments and …
Rhombus Launches AI Search to Power Instant Security Footage Investigation and Action
GlobeNewswire
·
April 15, 2025
SACRAMENTO, Calif., April 15, 2025 (GLOBE NEWSWIRE) -- Rhombus, a leader in cloud-managed physical security solutions, today announced the launch of Rhombus AI Search. The solution uses natural language processing to provide security teams with an …
OEM-Ready Axial Flux Motor: Turntide’s Breakthrough AF430S Speeds Electric Integration
GlobeNewswire
·
April 15, 2025
Gateshead, UK, April 15, 2025 (GLOBE NEWSWIRE) -- Turntide Technologies (Turntide), a leader of best-in-class electric motors, power electronics, energy storage, and thermal products for anything that moves, today announced a new advanced axial flux motor. …
West Red Lake Gold Highlights New Exploration Targets at Rowan Property
GlobeNewswire
·
April 15, 2025
VANCOUVER, British Columbia, April 15, 2025 (GLOBE NEWSWIRE) -- West Red Lake Gold Mines Ltd. (“West Red Lake Gold” or “WRLG” or the “Company”) (TSXV: WRLG) (OTCQB: WRLGF) is pleased to announce positive results from the 2024 regional surface mapping, …
Cyprumed Enters License and Option Agreement with MSD for the Development of Oral Peptide Therapeutics
GlobeNewswire
·
April 15, 2025
MSD obtains a Non-Exclusive License for Cyprumed’s delivery technology to develop oral peptide therapeutics Cyprumed will be eligible to receive up to $493 million in upfront, development, regulatory and sales milestones INNSBRUCK, Austria, April 15, 2025 …
1ST Biotherapeutics Joins The Michael J. Fox Foundation’s LITE Program to Advance LRRK2-Based Parkinson’s Disease Research
GlobeNewswire
·
April 15, 2025
Focus on the discovery of next-generation LRRK2 inhibitors to unlock novel biological mechanisms of action and advance new treatment options YONGIN, South Korea, April 15, 2025 – 1ST Biotherapeutics, Inc. (1STBIO), a clinical-stage biopharmaceutical …
Echo Sets May 15 as the Global Launch Date for its Centralized Crypto Exchange
GlobeNewswire
·
April 15, 2025
Douglas, Isle of Man, April 15, 2025 (GLOBE NEWSWIRE) -- Echo, a groundbreaking centralized cryptocurrency exchange, has announced that it will officially launch globally on May 15, 2025. The much-expected event is set to be a pivotal occasion for digital …
Integral Metals Responds to China’s Rare Earth Export Restrictions, Advancing Exploration at North American Properties
GlobeNewswire
·
April 15, 2025
CALGARY, Alberta, April 15, 2025 (GLOBE NEWSWIRE) -- Integral Metals Corp. (CSE: INTG | OTC: ITGLF | FSE: ZK9) (the “Company” or “Integral”) recognizes the recent decision by China’s Ministry of Commerce and the General Administration of Customs to …
Orderly Launches High-Yield OmniVault for Liquidity Providers
GlobeNewswire
·
April 15, 2025
SINGAPORE, April 15, 2025 (GLOBE NEWSWIRE) -- Permissionless liquidity layer Orderly has launched OmniVault, a solution that enables everyday DeFi users to become liquidity providers (LPs) to earn high yields on their assets passively. Utilizing market- …
Boehringer Ingelheim and Cue Biopharma partner to develop next-generation treatment for autoimmune and inflammatory diseases
GlobeNewswire
·
April 15, 2025
Partnership bolsters Boehringer’s autoimmune and inflammatory disease pipeline portfolio aiming to tackle areas of high unmet patient need. The agreement focuses on further research and development of a novel, first-in-class bispecific …
CORXEL Receives Study May Proceed Letter from the U.S. FDA for the Phase 2 Trial of CX11 in Patients with Obesity and Overweight Conditions
GlobeNewswire
·
April 15, 2025
The U.S. Phase 2 trial aims to evaluate efficacy and safety of CX11 in doses up to 200 mg and different titration schemes The trial is expected to enroll 250 patients to receive treatment over 36 weeks BERKELEY HEIGHTS, N.J., April 15, 2025 (GLOBE NEWSWIRE …
Galapagos Announces Departure of Thad Huston, CFO and COO, as of August 1, 2025
GlobeNewswire
·
April 15, 2025
Mechelen, Belgium; April 15, 2025, 07:30 CET; regulated information – inside information – Galapagos NV (Euronext …
Galapagos kondigt het vertrek van haar CFO en COO, Thad Huston, aan per 1 augustus 2025
GlobeNewswire
·
April 15, 2025
Mechelen, België; 15 april 2025, 07:30 CET; gereglementeerde informatie - voorwetenschap – Galapagos NV (Euronext …
Press Release: Sanofi’s respiratory pipeline advances with new data in asthma and plans for new clinical studies in COPD
GlobeNewswire
·
April 15, 2025
Sanofi’s respiratory pipeline advances with new data in asthma and plans for new clinical studies in COPD New phase 2 data for amlitelimab show efficacy in heterogeneous inflammatory asthma Lunsekimig now targeting chronic rhinosinusitis and COPD in …
Communiqué de presse : Le portefeuille de traitements contre les maladies respiratoires de Sanofi s’enrichit de nouvelles données sur l’asthme et prévoit de nouvelles études cliniques sur la BPCO
GlobeNewswire
·
April 15, 2025
Le portefeuille de traitements contre les maladies respiratoires de Sanofi s’enrichit de nouvelles données sur l’asthme et prévoit de nouvelles études cliniques sur la BPCO De nouvelles données de phase II démontrent l’efficacité de l’amlitélimab dans le …